Teva Pharmaceutical Industries Limited (TEVA) Stock Price

31.74 ▲ +0.20 (+0.63%)
Open: 31.99 Vol: 3.79M Day's range: 31.51 - 31.99 Dec 24, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
TEVA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 31.73▼ 31.69▲ 31.66▲ 31.03▲ 29.45▲
MA10 31.75▼ 31.63▲ 31.53▲ 30.54▲ 26.03▲
MA20 31.71▲ 31.51▲ 31.24▲ 29.18▲ 22.49▲
MA50 31.66▲ 30.97▲ 30.56▲ 25.00▲ 18.92▲
MA100 31.53▲ 30.49▲ 29.71▲ 21.82▲ 17.73▲
MA200 31.31▲ 29.49▲ 27.61▲ 19.00▲ 13.38▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.006▼ -0.006▼ 0.014▲ 0.028▲ 1.096▲
RSI 53.675▲ 72.084▲ 79.535▲ 85.021▲ 81.019▲
STOCH 44.851     60.365     79.207     92.370▲ 93.843▲
WILL %R -58.974     -30.000     -18.966▲ -6.266▲ -1.814▲
CCI -42.329     86.897     121.011▲ 161.459▲ 128.436▲
Latest Filters Detected On TEVA
▲ RSI&STOCH $TEVA Overbought RSI + Stochastic Set Alert
▲ BREAK $TEVA Price Breaks 60 Days High Set Alert
▲ BREAK $TEVA Price Breaks 30 Days High Set Alert
▲ BREAK $TEVA Price Breaks 20 Days High Set Alert
▲ BREAK $TEVA Price Breaks 10 Days High Set Alert
Teva Pharmaceutical Industries Limited News
$100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
Thursday, December 25, 2025 05:30 AM
Teva Pharmaceutical Indus (NYSE: TEVA) has outperformed the market over the past 5 years by 13.95% on an annualized basis producing an average annual return of 27.15%. Currently, Teva Pharmaceutical ...
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
Wednesday, December 24, 2025 05:58 AM
The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial discipline.Moody's affirmed Teva's ...
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth ...
Wednesday, December 24, 2025 04:36 AM
The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial discipline.Moody's affirmed Teva's B1a rating and revised Teva's outlook to positive from ...
TEVA historical stock data
date open high low close volume
24/12/25 31.99 31.99 31.51 31.74 3,794,300
23/12/25 31.38 31.58 31.18 31.54 15,426,500
22/12/25 30.72 31.28 30.50 31.21 8,231,900
19/12/25 30.10 30.56 29.89 30.35 10,758,600
18/12/25 30.115 30.39 29.875 30.32 6,412,432
17/12/25 30.12 30.24 29.88 30.06 7,229,000
16/12/25 30.125 30.42 29.8401 30.10 6,632,917
15/12/25 29.78 30.44 29.7007 30.13 12,952,709
12/12/25 30.00 30.13 29.555 29.79 8,272,925
11/12/25 29.59 30.20 29.47 30.18 9,878,900
Quote Details
52wk Low:12.465
52wk High:31.99
Vol:3.79M
Avg Vol(3m):217.9M
1Y Chng:+55.28%
1M Chng:+22.88%
Add to Watch List
More Information
Index N/A
Market Cap. 36.41B